Results 341 to 350 of about 3,627,015 (399)
SARS-CoV-2 infection rebound among patients receiving antiviral agents, convalescent plasma, or no treatment: a systematic review with meta-analysis. [PDF]
Blood TransfusCruciani M +5 more
europepmc +1 more source
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects. [PDF]
Mar Life Sci TechnolNagahawatta DP +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hepatology, 2020
Sustained virologic response (SVR) after direct acting antiviral agents (DAAs) holds promise for reducing hepatocellular cancer (HCC). DAAs have recently been available long enough to estimate the long‐term risk. We conducted a retrospective cohort study
F. Kanwal +5 more
semanticscholar +1 more source
Sustained virologic response (SVR) after direct acting antiviral agents (DAAs) holds promise for reducing hepatocellular cancer (HCC). DAAs have recently been available long enough to estimate the long‐term risk. We conducted a retrospective cohort study
F. Kanwal +5 more
semanticscholar +1 more source
Mayo Clinic Proceedings, 1987
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources
2021
Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance.
Fatemeh Abdi +4 more
openaire +3 more sources
Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance.
Fatemeh Abdi +4 more
openaire +3 more sources
Amino Acid and Peptide‐Based Antiviral Agents
ChemMedChem, 2021A significant number of antiviral agents used in clinical practice are amino acids, short peptides, or peptidomimetics. Among them, several HIV protease inhibitors (e. g. lopinavir, atazanavir), HCV protease inhibitors (e. g.
Andrzej S. Skwarecki +2 more
semanticscholar +1 more source
HEPATOTOXICITY OF ANTIVIRAL AGENTS
Gastroenterology Clinics of North America, 1995Because most therapeutic agents used for viral infections are relatively new, experience with their adverse effects is still evolving. Hepatic toxicity has not been among the most important concerns with this class of drugs so far. Liver damage has been increasingly noted with accumulating experience, especially with antiretroviral drugs and those used
Barbara A. Styrt, Joel P. Freiman
openaire +2 more sources
Thiazole Compounds as Antiviral Agents: An Update.
Medicinal chemistry, 2020BACKGROUND Thiazole is a wonder nucleus owing to its various pharmaceutical applications. Thiazole containing compounds (thiazoles) have shown various biological activities like antioxidant, analgesic, antibacterial, anticancer, antiallergic ...
I. Singh, Shiv K. Gupta, Sanjay Kumar
semanticscholar +1 more source